Recipharm and Adroit Science Form Collaboration
News Mar 26, 2015
Recipharm AB and Adroit Science AB have announced the formation of a new strategic collaboration. Adroit Science AB will support Recipharm’s pharmaceutical development with high quality solid state characterization services.
By combining expertise in formulation development, API development, chemical analysis and solid state characterization, both the speed and cost of development can be reduced whilst, at the same time, quality is improved.
“I am very excited about this collaboration”, says Carl-Johan Spak, Executive Vice President, Development & Technology at Recipharm. “With the addition of development services from Adroit, we will have a very competitive offering, which will help our customers to progress their projects in a highly efficient way. Adroit Science AB has fast established itself as one of the leading providers of solid state characterization services in Northern Europe. Indeed, we can offer an even better service to our customers through this collaboration, including complete development from molecule to product.”
“Adroit Science and Recipharm have already cooperated in a number of successful projects, and this formal partnership marks the logical next step in the mutual development of our strategic relationship. We are delighted to join forces with a leading CDMO like Recipharm and predict that this will bring new opportunities in worldwide customer support” remarked Hans Gredeby, CEO of Adroit Science AB.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE